Skape
Skape Bio utilizes an AI platform integrating generative protein design with native membrane biology to create novel miniprotein modulators for G protein-coupled receptors (GPCRs). The company employs proprietary high-throughput screening technologies to validate these designed biologics directly within human cells. This platform unlocks previously inaccessible GPCR drug targets by delivering functional agonists and antagonists with high developability.
Traction –/10
HQ unknown
Updated 3 days ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Skape Bio utilizes an AI platform integrating generative protein design with native membrane biology to create novel miniprotein modulators for G protein-coupled receptors (GPCRs). The company employs proprietary high-throughput screening technologies to validate these designed biologics directly within human cells. This platform unlocks previously inaccessible GPCR drug targets by delivering functional agonists and antagonists with high developability.